Daiichi Sankyo (4568) - Is Luck Running Out?
Daiichi Sankyo (4568 JP) has been seen as leading something of a charmed life in recent months, most notably when Sun Pharmaceutical (SUNP IN) paid...
167 Views
Takeda - Brigantinib Gets FDA Approval
Earlier this year, Takeda Pharmaceutical Co Ltd (4502 JP) spent US$4bil on Ariad Pharmaceuticals Inc (ARIA US), thereby acquiring a company with a...
279 Views
RHT Health Trust - Potential Privatization or Just Noise?
According to the latest news/rumors, Fortis Healthcare is considering a buyout of RHT Health Trust (RHT SP) and they may bring in a new investor to...
403 Views
The Week That Was in NorthAsia@Smartkarma - Jelly Drinks, Dental Implants, & Tires
This is the inaugural report of "The Week That Was in North Asia@Smartkarma. This is a collaborative report among Travis Lundy, Mio Kato, CFA,...
284 Views
Daiichi Sankyo - Downside Limited from Here
With Effient (prasugrel, antiplatelet) and Savaysa (edoxaban, anti-coagulant), Daiichi Sankyo looked relatively well prepared to see through the...
193 Views